Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 2, randomized, double-blind, cross-over study of S-600918 in subjects with refractory/unexplained chronic cough

Next Previous
Trial Profile

A Phase 2, randomized, double-blind, cross-over study of S-600918 in subjects with refractory/unexplained chronic cough

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 02 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs S-600918 (Primary)
  • Indications Cough
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Shionogi

    • Most Recent Events

    • 02 Oct 2019 Status changed from recruiting to completed, according to a Shionogi media release.
    • 02 Oct 2019 According to a Shionogi media release, results from the study were presented at the European Respiratory Society International Congress (ERS 2019).
    • 02 Oct 2019 Results presented in a Shionogi media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top